Our results support the option of addition of basal insulin in patients with type 2 diabetes inadequately controlled by metformin (The Lancet)
Diabetes News Service
Our results support the option of addition of basal insulin in patients with type 2 diabetes inadequately controlled by metformin (The Lancet)
For iPhone and iPad | For Android devices
For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com
Website by Wired up Wales